Veeva Systems Net Change in Property, Plant, and Equipment 2012-2025 | VEEV
Veeva Systems annual/quarterly net change in property, plant, and equipment history and growth rate from 2012 to 2025. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
- Veeva Systems net change in property, plant, and equipment for the quarter ending January 31, 2025 was $-0.021B, a 21.67% decline year-over-year.
- Veeva Systems net change in property, plant, and equipment for the twelve months ending January 31, 2025 was $-0.056B, a 6.39% decline year-over-year.
- Veeva Systems annual net change in property, plant, and equipment for 2025 was $-0.021B, a 21.67% decline from 2024.
- Veeva Systems annual net change in property, plant, and equipment for 2024 was $-0.026B, a 93.87% increase from 2023.
- Veeva Systems annual net change in property, plant, and equipment for 2023 was $-0.014B, a 4.94% decline from 2022.
| Veeva Systems Annual Net Change in Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2025 | $-21 |
| 2024 | $-26 |
| 2023 | $-14 |
| 2022 | $-14 |
| 2021 | $-9 |
| 2020 | $-4 |
| 2019 | $-10 |
| 2018 | $-11 |
| 2017 | $-8 |
| 2016 | $-22 |
| 2015 | $-27 |
| 2014 | $-3 |
| 2013 | $-2 |
| 2012 | $-1 |
| 2011 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $38.234B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $12.982B | 134.88 |
| Tempus AI (TEM) | United States | $10.012B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.465B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.309B | 67.32 |
| Privia Health (PRVA) | United States | $2.902B | 198.33 |
| Enovis (ENOV) | United States | $1.848B | 10.30 |
| Clover Health Investments (CLOV) | United States | $1.791B | 0.00 |
| Schrodinger (SDGR) | United States | $1.498B | 0.00 |
| Phreesia (PHR) | United States | $1.456B | 0.00 |
| Omnicell (OMCL) | United States | $1.281B | 22.59 |
| Azenta (AZTA) | United States | $1.258B | 58.47 |
| 10x Genomics (TXG) | United States | $1.024B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.534B | 0.00 |
| Talkspace (TALK) | United States | $0.486B | 145.25 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Claritev (CTEV) | United States | $0.473B | 0.00 |
| Standard BioTools (LAB) | United States | $0.395B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 805.00 |
| Nyxoah SA (NYXH) | Belgium | $0.274B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.141B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| 111 (YI) | China | $0.067B | 0.00 |
| Outset Medical (OM) | United States | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |